Chen Chin-Kuo, Shen Shih Chieh, Lee Li-Ang, Sun Ming-Hui, Chen Ning-Hung, Chuang Li-Pang, Li Hsueh-Yu
Department of Otolaryngology-Head and Neck Surgery, Sleep Center, Chang Gung Memorial Hospital (Linkou), Taoyuan City, Taiwan.
College of Medicine, Chang Gung University, Taoyuan City, Taiwan.
Nat Sci Sleep. 2021 Oct 15;13:1877-1885. doi: 10.2147/NSS.S331880. eCollection 2021.
Obstructive sleep apnea (OSA) is characterized by recurring hypoxic-apneic events during sleep, and labyrinthine vascular compromise is a pathophysiologic hallmark of idiopathic sudden sensorineural hearing loss (ISSNHL). Some reports have discussed the relationship between OSA and hearing impairment; however, few have examined hearing prognosis in OSA and patients without OSA with ISSNHL. We aimed to investigate clinical manifestations of ISSNHL in patients with OSA, including severity of hearing loss and response to treatment.
A case-control study was conducted by extracting data from the sleep center and cochlea center databases of the Chang Gung Memorial Hospital. A retrospective chart review was performed to include confirmed adult OSA patients diagnosed with unilateral ISSNHL. Age and sex-matched patients without OSA with ISSNHL were enrolled as controls. Pure-tone average (PTA) thresholds were measured at specific frequencies. Changes in PTA before and after standard treatment with oral prednisolone (1mg/kg/day for 5 days, then tapered) and between participants with OSA and without OSA were compared. Standard treatment was given to all ISSNHL patients.
Twenty-eight out of 8500 (0.33%) OSA patients experienced subsequent ISSNHL in 9 years. Patients with OSA (n=28) had poorer high-frequency perception in the unaffected ear than the patients without OSA (n=120), although the difference was not significant. Hearing in the affected ear among patients with OSA was comparable to that patients without OSA at individual frequencies and average, suggesting no difference in hearing loss in the affected ear between the two groups. In terms of high-frequencies (4000 and 8000 Hz) perception, patients with OSA had significantly poorer responses to steroid treatment than patients without OSA.
ISSNHL may be one of the auditory complications associated with OSA. Patients with OSA had poorer prednisolone related hearing improvement in high frequencies than patients without OSA. Despite study limitations, OSA-related hypoxia and snoring noise is hazardous to hearing and standard treatments with CPAP is suggested in OSA patients for both holistic and auditory health.
阻塞性睡眠呼吸暂停(OSA)的特征是睡眠期间反复出现缺氧-呼吸暂停事件,而迷路血管受损是特发性突发性感音神经性听力损失(ISSNHL)的病理生理标志。一些报告讨论了OSA与听力障碍之间的关系;然而,很少有研究探讨OSA患者和无OSA的ISSNHL患者的听力预后。我们旨在研究OSA患者中ISSNHL的临床表现,包括听力损失的严重程度和对治疗的反应。
通过从长庚纪念医院睡眠中心和耳蜗中心数据库中提取数据进行病例对照研究。进行回顾性病历审查,纳入确诊为单侧ISSNHL的成年OSA患者。年龄和性别匹配的无OSA的ISSNHL患者作为对照。在特定频率下测量纯音平均(PTA)阈值。比较口服泼尼松龙标准治疗(1mg/kg/天,共5天,然后逐渐减量)前后PTA的变化以及OSA患者和无OSA患者之间的变化。所有ISSNHL患者均接受标准治疗。
8500例OSA患者中有28例(0.33%)在9年内出现了随后的ISSNHL。OSA患者(n=28)未受影响耳的高频感知比无OSA患者(n=120)差,尽管差异不显著。OSA患者患耳的听力在各个频率和平均值上与无OSA患者相当,表明两组患耳的听力损失无差异。在高频(4000和8000Hz)感知方面,OSA患者对类固醇治疗的反应明显比无OSA患者差。
ISSNHL可能是与OSA相关的听觉并发症之一。OSA患者在高频方面与无OSA患者相比,泼尼松龙相关的听力改善较差。尽管研究存在局限性,但OSA相关的缺氧和打鼾噪音对听力有害,建议对OSA患者采用持续气道正压通气(CPAP)标准治疗以促进整体和听觉健康。